Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
02 September 2020 | Story Andre Damons | Photo Supplied
Dr Satyajit Tripathy
Dr Satyajit Tripathy, a postdoctoral fellow from the Department of Pharmacology and Physiology, won the medal for the best oral performance at a UNESCO/UNITWIN network web seminar attended by more than 300 people from various institutions around the world.

A postdoctoral fellow in Pharmacology at the University of the Free State (UFS) was awarded a medal for the best oral e-poster presentation (Postdoctoral Fellow category) at a UNESCO/UNITWIN Network web seminar.

The two-day webinar with the theme Current concepts of Environmental Pollution by Electromagnetic field and Coronavirus was held in early August and was attended by more than 300 delegates from approximately 30 institutions from different countries.

Dr Satyajit Tripathy from the Department of Pharmacology won the medal for his outstanding research presentation on Employment of old options to control novel Coronavirus: Pros and Cons (authors: Barsha Dassarma, Satyajit Tripathy, MG Matsabisa). His presentations looked at immunotherapeutic techniques, such as the convalescent plasma (CP) therapy and possible diverse modes of action of the antimalarial drug hydroxychloroquine (HCQ) against COVID-19 infection.

The award will serve as motivation

He was excited to hear that he had won the award, says Dr Tripathy.

“I never thought I would win, but I tried my best. On the topic of possible modes of action of HCQ against the viral infection, we have published in the ‘International Journal of Antimicrobial Agents’ (S Tripathy, B Dassarma, H Chabalala, S Roy, and MG Matsabisa / International Journal of Antimicrobial Agents 56 (2020) 106028). All the authors are grateful to Prof Glen Taylor, Research Director at the UFS, and the UFS Department of Pharmacology, for giving us the opportunity,” says Dr Tripathy. 
According to him, receiving this award is a validation and boost to his confidence. “I am thankful to Prof Motlalepula Matsabisa (supervisor) and Dr Barsha Dassarma (my wife), who are also contributing actively to this project. Moreover, the award is a symbol of respect for my work and the acceptance of a greater responsibility to keep the UFS flag flying high.”
Dr Tripathy goes further to say that it will motivate him to work on HCQ or nano-HCQ delivery research on Coronaviruses. In his doctoral study, it has been found that chitosan-based nanochloroquine delivery increases antimalarial efficacy against rodent parasites. Against the Coronavirus, this type of approach might work to reduce the dose and increase the efficacy of HCQ, explains Dr Tripathy. 

Immediate saviour from the pandemic

In his presentation, Dr Tripathy argues that while the world is finding expedited approvals for the development of vaccines that are time-dependent, preventative, and possibly not a cure, physicians are considering the convalescent plasma (CP) therapy as an immediate saviour, and the antimalarial drug hydroxychloroquine (HCQ) as therapeutic options against COVID-19 infection, after assessing results from larger prospective, randomised, dose-determining controlled clinical trials. 
He concludes that, “Overall, in this situation of unavailability of specific medication, the CP therapy and HCQ treatment might act as an immediate saviour for society from the pandemic.”

News Archive

Kovsie student aims for the record books
2011-10-11

 
Potential Guinness World Record-holder, Hermann van Heerden
Photo: Phelekwa Mpono

The Guinness World Record for the longest continuous wheelie in a wheelchair was achieved by Michael Miller of the United States, who covered a distance of 16,12 km on the rear wheels of his wheelchair on 8 August 2009.

On 11 October 2011, Hermann van Heerden, a second-year Kovsie student, will attempt to set a Guinness World Record for the longest wheelie in a wheelchair in a stationary position. The 22-year-old disabled student from the University of the Free State (UFS) will manoeuvre his wheelchair so that the front wheels lift off the ground.

Hermann, who is studying for a BEd degree, was born with spina bifida, a developmental congenital disorder caused by the incomplete closing of the embryonic neural tube. He has been in a wheelchair since he was a toddler.

Hermann’s Guinness World Record attempt forms part of the ten-year celebrations of the Unit for Students with Disabilities (USD) at the UFS. The unit was established in February 2001, with fifteen registered students, but currently supports 143 registered students. The USD focuses on promoting equity for students with disabilities, including access to courses, buildings, learning materials, residences, leisure and sports activities and the opportunity to succeed in such activities.

The unit supports students with specific learning difficulties (dyslexia, attention deficit hyperactivity disorder); mobility–impaired students (wheelchair users and amputees, as well as those suffering from cerebral palsy, muscle dystrophy, spina bifida and multiple sclerosis); visually-impaired students; hearing-impaired students, students suffering from “other” conditions (mental impairment ((schizophrenia)), epilepsy, panic disorder) and those with temporary impairments (broken hand).

Hermann said that he would like to use his record attempt as a means of raising money for the USD and welcomes sponsorships. “The USD has only been good to me ever since I registered at the UFS. Every time I had a question, they answered it. Every time I had a problem with a class, they resolved it. This year, the unit has its ten-year anniversary and I thought it was time for me to give back.”
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept